Novo Holdings Leads $100 Million Series C Financing for Asceneuron
Novo Holdings has led a $100 million Series C financing
German Biotech CatalYm Raises $150 Million for Phase 2b Cancer Studies
CatalYm, a German biotech company specializing in cancer immunotherapy, has
Myricx Bio’s NMTi-ADCs Achieve Tumor Regression in Preclinical Trials
The field of cancer treatment is on the cusp of
Pharma Giant Eli Lilly to Buy Biotech Firm Morphic for $3.2 Billion
Eli Lilly and Company, a global leader in pharmaceutical development,
Brisbane Biotech Gelomics Raises $2.2 Million in Pre-Seed Funding
In a significant stride towards ethical biomedical advancements, Brisbane-based biotech
Alumis IPO Priced at $16, Targets $210M Funding
Alumis, a clinical-stage immunology biotech company, has priced its downsized
Unlocking New Frontiers: How Generative AI is Transforming Protein Design and Drug Discovery
Abstract This report explores the transformative impact of generative artificial
Manulife and World Economic Forum Launch Longevity Innovation Challenge
Manulife and World Economic Forum Launch Longevity Innovation Challenge In
Impact of Space Travel on Immune Function and Potential Countermeasures
Abstract Space travel poses significant challenges to human health, particularly
UroGen Aims to Raise $107M to Advance Innovative Obesity and Bladder Cancer Therapies
Introduction Overview of UroGen: UroGen Pharma Ltd., headquartered in Princeton,
Diamond Biofund Becomes First Biotech VC Firm Listed on Taiwan Stock Exchange
Introduction: Diamond Biofund has recently achieved a groundbreaking milestone by
Marea Biotech Secures $190 Million for Heart Disease Research
Introduction Marea Biotech, a pioneering company in the biotech industry,
Illumina Faces Potential $7 Billion Loss from Forced Grail Sale: An Analysis
1. Introduction Background on Illumina and Grail Illumina, Inc. is
Revolutionizing Dairy: How Biotech Companies are Producing Milk Without Cows
Abstract This report explores the emerging field of animal-free dairy
EU Sets New Goals for Advancing Biotechnology and Biomanufacturing
Executive Summary The EU Biotech and Biomanufacturing Initiative is a
Debate Highlights: Can Aging Be Halted or Reversed? Experts Weigh In
Debating the Future: Can Aging Be Halted or Reversed? Introduction
AI-Powered Drug Repurposing by BioXcel Therapeutics Accelerates Development of New Neuropsychiatric Treatments
1. Introduction BioXcel Therapeutics is a biopharmaceutical company leveraging artificial
CRISPR-Cas9 Enhances Rice Yields Without Introducing Foreign DNA
This study explores the use of CRISPR-Cas9 technology to increase
Epigenetic Stability Linked to Lifespan in Mammals, Research Show
Introduction The recent study published in the journal Science Advances on
Orna Therapeutics Acquires ReNAgade Therapeutics to Enhance RNA Medicine Development
Orna Therapeutics, a Massachusetts-based biotech firm specializing in circular RNA
Limula Secures $6.8M Funding to Enhance Cell and Gene Therapy Manufacturing
Limula, an innovative biotech company, recently secured $6.8 million in
Forbion-Backed VectorY Therapeutics Raises $138M for ALS and Neurodegenerative Disease Research
VectorY Therapeutics, a biotechnology company based in Amsterdam, Netherlands, has
Vector Laboratories and Absolute Biotech Announce Merger to Strengthen Life Sciences Capabilities
Vector Laboratories and Absolute Biotech have announced a merger, aiming
AstraZeneca Completes Equity Investment in Cellectis to Enhance Gene Therapy Development
AstraZeneca has completed its planned equity investment in Cellectis, a
MOST POPULAR
